Voyager Pharmaceutical, Develops drugs for diseases associated with aging and development, withdrew its IPO filing Tuesday afternoon. The company cited "market conditions" as the reason for its withdrawal. W.R. Hambrecht was slated as the underwriter on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
